Ceribell Q2 revenue up 33% to $28.1M; raises FY2026 guidance to $114-117M

Ceribell, Inc.

Total revenue $28.1M, up 33% YoY; product revenue $21.2M, subscription $6.9M.
Net loss $19.3M ($0.51/share) vs $13.6M loss YoY; adjusted EBITDA loss $9.8M.
Gross margin 92% (up from 88%) on cost cuts, Vietnam line, and tariff refunds.
New $60M credit facility (term loan + revolver) refinances debt; cash $129.3M.
Raised FY2026 revenue guidance to $114-117M (28-31% growth); FDA clearances for algorithms and hardware.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.